1. Home
  2. ATAI vs FMBH Comparison

ATAI vs FMBH Comparison

Compare ATAI & FMBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • FMBH
  • Stock Information
  • Founded
  • ATAI 2018
  • FMBH 1865
  • Country
  • ATAI Netherlands
  • FMBH United States
  • Employees
  • ATAI N/A
  • FMBH N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • FMBH Major Banks
  • Sector
  • ATAI Health Care
  • FMBH Finance
  • Exchange
  • ATAI Nasdaq
  • FMBH Nasdaq
  • Market Cap
  • ATAI 1.1B
  • FMBH 974.1M
  • IPO Year
  • ATAI 2021
  • FMBH N/A
  • Fundamental
  • Price
  • ATAI $5.84
  • FMBH $35.73
  • Analyst Decision
  • ATAI Strong Buy
  • FMBH Hold
  • Analyst Count
  • ATAI 5
  • FMBH 5
  • Target Price
  • ATAI $14.00
  • FMBH $43.40
  • AVG Volume (30 Days)
  • ATAI 7.0M
  • FMBH 67.7K
  • Earning Date
  • ATAI 11-14-2025
  • FMBH 10-30-2025
  • Dividend Yield
  • ATAI N/A
  • FMBH 2.80%
  • EPS Growth
  • ATAI N/A
  • FMBH 12.54
  • EPS
  • ATAI N/A
  • FMBH 3.65
  • Revenue
  • ATAI $2,309,000.00
  • FMBH $335,099,000.00
  • Revenue This Year
  • ATAI $736.04
  • FMBH N/A
  • Revenue Next Year
  • ATAI N/A
  • FMBH $4.16
  • P/E Ratio
  • ATAI N/A
  • FMBH $9.79
  • Revenue Growth
  • ATAI 510.85
  • FMBH 5.91
  • 52 Week Low
  • ATAI $1.04
  • FMBH $27.58
  • 52 Week High
  • ATAI $6.75
  • FMBH $43.86
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 54.11
  • FMBH 41.94
  • Support Level
  • ATAI $5.50
  • FMBH $36.32
  • Resistance Level
  • ATAI $6.23
  • FMBH $37.20
  • Average True Range (ATR)
  • ATAI 0.47
  • FMBH 1.12
  • MACD
  • ATAI -0.05
  • FMBH 0.01
  • Stochastic Oscillator
  • ATAI 36.10
  • FMBH 39.55

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

Share on Social Networks: